INDRAPRASTHA MEDICAL CORPORATION
|
INDRAPRASTHA MEDICAL CORPORATION Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 17.56 | 13.52 | 9.40 | 6.39 | 0.25 |
| CEPS(Rs) | 22.40 | 17.89 | 13.68 | 10.21 | 3.89 |
| DPS(Rs) | 4.50 | 4.50 | 3.00 | 2.50 | - |
| Book NAV/Share(Rs) | 65.09 | 52.12 | 41.39 | 35.50 | 29.75 |
| Tax Rate(%) | 25.58 | 25.37 | 26.48 | 25.86 | 45.69 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 18.01 | 15.53 | 13.72 | 12.87 | 6.57 |
| EBIT Margin(%) | 16.41 | 13.67 | 11.06 | 9.29 | 1.24 |
| Pre Tax Margin(%) | 15.95 | 13.35 | 10.67 | 8.90 | 0.70 |
| PAT Margin (%) | 11.87 | 9.96 | 7.84 | 6.60 | 0.38 |
| Cash Profit Margin (%) | 15.14 | 13.18 | 11.42 | 10.53 | 5.81 |
| Performance Ratios | |||||
| ROA(%) | 20.44 | 19.39 | 16.94 | 13.12 | 0.53 |
| ROE(%) | 29.97 | 28.92 | 24.44 | 19.60 | 0.86 |
| ROCE(%) | 41.43 | 39.70 | 34.46 | 27.58 | 2.80 |
| Asset Turnover(x) | 1.72 | 1.95 | 2.16 | 1.99 | 1.39 |
| Sales/Fixed Asset(x) | 2.40 | 2.34 | 2.27 | 1.92 | 1.36 |
| Working Capital/Sales(x) | 5.37 | 8.73 | 11.76 | 13.89 | 24.03 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.42 | 0.43 | 0.44 | 0.52 | 0.74 |
| Receivable days | 18.01 | 18.57 | 18.54 | 22.75 | 43.60 |
| Inventory Days | 1.95 | 2.34 | 3.06 | 3.85 | 6.19 |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 21.98 | 12.70 | 8.27 | 9.14 | 211.45 |
| PCE(x) | 17.24 | 9.60 | 5.68 | 5.73 | 13.82 |
| Price/Book(x) | 5.93 | 3.30 | 1.88 | 1.65 | 1.81 |
| Yield(%) | 1.17 | 2.62 | 3.86 | 4.28 | - |
| EV/Net Sales(x) | 2.37 | 1.08 | 0.53 | 0.53 | 0.76 |
| EV/Core EBITDA(x) | 12.05 | 6.42 | 3.63 | 3.98 | 11.36 |
| EV/EBIT(x) | 14.45 | 7.93 | 4.81 | 5.67 | 60.97 |
| EV/CE(x) | 5.39 | 2.83 | 1.54 | 1.01 | 1.08 |
| M Cap / Sales | 2.61 | 1.26 | 0.65 | 0.60 | 0.80 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.97 | 13.29 | 23.70 | 44.80 | -26.17 |
| Core EBITDA Growth(%) | 26.95 | 30.81 | 36.88 | 186.74 | -52.97 |
| EBIT Growth(%) | 30.80 | 40.10 | 47.26 | 981.00 | -85.90 |
| PAT Growth(%) | 29.87 | 43.89 | 46.96 | 2,415.88 | -94.66 |
| EPS Growth(%) | 29.87 | 43.89 | 46.96 | 2,415.62 | -94.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.41 | 1.86 | 1.72 | 1.68 | 1.22 |
| Quick Ratio(x) | 2.37 | 1.82 | 1.66 | 1.58 | 1.14 |
| Interest Cover(x) | 35.50 | 41.91 | 28.38 | 24.19 | 2.28 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of INDRAPRASTHA MEDICAL CORPORATION
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAPRASTHA MEDICAL CORPORATION | ₹3,784.5 Cr | -6.4% | -8.4% | -25.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹104,381.0 Cr | 2.5% | 3.4% | -0.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,944.5 Cr | -3.2% | -5.6% | -14% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹68,112.3 Cr | -1.4% | 5.8% | 24.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,761.1 Cr | -0.3% | 2.1% | 41.6% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,628.6 Cr | -4.9% | 1.7% | 13% | Stock Analytics | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | -6.4% |
-8.4% |
-25.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses
